Biogen Inc (MEX:BIIB)
MXN 3250 0 (0%) Market Cap: 479.05 Bil Enterprise Value: 580.39 Bil PE Ratio: 14.51 PB Ratio: 1.43 GF Score: 70/100

Q2 2024 Biogen Inc Earnings Call Transcript

Aug 01, 2024 / 12:30PM GMT
Release Date Price: MXN3940 (-0.88%)
Editor Biogen Inc.;Editor

Please stand by for streaming text

Operator;Christopher A. Viehbacher

Philly from those in our for our agents. We provide a comprehensive list of risk factors in our SEC filings, which I encourage you to review our earnings release and other documents related to our results as well as the reconciliation between GAAP and non-GAAP results discussed on the call can be found in the Investors section at Biogen.com. We have also posted the slides on our website that will be used during this call. On today's call, I'm joined by our President and Chief Executive Officer, Chris Viehbacher, our head in President of North America, Alicia IMO, Dr. Prius single Head of Development, Mike McDonnell, Chief Financial Officer, and will be introducing Dr. Travis Murdoch from high bio on the call. We'll make some opening comments and then we'll move to the Q&A session and to allow us to get through as many questions as possible, we ask that you limit yourself to one question. With that, I'll now turn the call over to Chris.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot